Autologous stromal vascular fraction therapy for rheumatoid arthritis: rationale and clinical safety

Advancements in rheumatoid arthritis (RA) treatment protocols and introduction of targeted biological therapies have markedly improved patient outcomes, despite this, up to 50% of patients still fail to achieve a significant clinical response. In veterinary medicine, stem cell therapy in the form of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez, Jorge Paz, Murphy, Michael P, Hong, Soonjun, Madrigal, Marialaura, March, Keith L, Minev, Boris, Harman, Robert J, Chen, Chien-Shing, Timmons, Ruben Berrocal, Marleau, Annette M, Riordan, Neil H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296619/
https://www.ncbi.nlm.nih.gov/pubmed/22313603
http://dx.doi.org/10.1186/1755-7682-5-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296619/
https://www.ncbi.nlm.nih.gov/pubmed/22313603
http://dx.doi.org/10.1186/1755-7682-5-5

Ejemplares similares